Observational studyBrain and behavior2025
Association Between Free Triiodothyronine to Free Thyroxine Ratio and Hemorrhagic Transformation After Intravenous Thrombolysis in Acute Ischemic Stroke Patients.
Observational study in Brain and behavior, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundHemorrhagic transformation (HT) is a critical complication following intravenous thrombolysis (IVT) in acute ischemic stroke (AIS). Emerging evidence indicates thyroid homeostasis' potential role in cerebrovascular outcomes, with the free triiodothyronine to free thyroxine (FT3/FT4) ratio demonstrating superior predictive value over isolated thyroid hormone measurements. This observational study works on elucidating the relation between pre-treatment FT3/FT4 ratios and post-thrombolytic HT occurrence in AIS populations.
methodThe research consecutively enrolled AIS patients receiving IVT therapy between January 2020 and August 2024. Clinical information from patients was gathered, and to examine the link between the FT3/FT4 ratio and post-IVT HT, we performed both multivariate and univariate logistic regression analyses. The optimal cutoff value was identified through the ROC curve analysis. The relation between clinical outcomes in HT patients and the FT3/FT4 ratio was further assessed using correlation analysis.
resultA cohort of 251 patients with AIS was recruited; among them, 46 patients experienced HT following IVT. Multivariate regression analysis presented a notable correlation between the FT3/FT4 ratio and the occurrence of HT, with an OR of 0.444 [95% CI 0.209-0.946, p = 0.035]. The area under the ROC curve (AUC) of the FT3/FT4 ratio for discriminating HT from non-HT was 0.774 (95% CI 0.695-0.853, p < 0.001), with an optimal cutoff value of 0.211. Correlation analysis demonstrated that FT3/FT4 levels were negatively related to baseline NIHSS score (r = -0.317, p = 0.032), In patients with HT, the NIHSS score at 24 h following thrombolysis (r = -0.367, p = 0.012) and the mRS score at 3 months post-onset (r = -0.394, p = 0.007) demonstrated significant correlations.
conclusionIn patients with AIS, lower FT3/FT4 levels were found to be a potential predictive marker for HT. Nevertheless, no association was observed between FT3/FT4 levels and HT types. Moreover, lower FT3/FT4 levels were indicative of poorer clinical outcomes in HT patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.